• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕激素受体异构体平衡在正常和肿瘤乳腺细胞中的改变调节干细胞群体。

Alterations in Progesterone Receptor Isoform Balance in Normal and Neoplastic Breast Cells Modulates the Stem Cell Population.

机构信息

Área de Investigaciones, Instituto de Oncología, "Ángel H. Roffo", Av. San Martín 5481, Buenos Aires C1417DTB, Argentina.

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.

出版信息

Cells. 2020 Sep 11;9(9):2074. doi: 10.3390/cells9092074.

DOI:10.3390/cells9092074
PMID:32932770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7564437/
Abstract

To investigate the role of PR isoforms on the homeostasis of stem cells in the normal and neoplastic mammary gland, we used PRA and PRB transgenic mice and the T47D human breast cancer cell line and its derivatives, T47D YA and YB (manipulated to express only PRA or PRB, respectively). Flow cytometry and mammosphere assays revealed that in murine breast, overexpression of PRB leads to an increase in luminal and basal progenitor/stem cells. Ovariectomy had a negative impact on the luminal compartment and induced an increase in mammosphere-forming capacity in cells derived from WT and PRA mice only. Treatment with ICI 182,780 augmented the mammosphere-forming capacity of cells isolated from WT and PRA mice, whilst those from PRB remained unaltered. T47D YB cells showed an increase in the CD44/CD24 subpopulation; however, the number of tumorspheres did not vary relative to T47D and YA, even though they were larger, more irregular, and had increased clonogenic capacity. T47D and YA tumorspheres were modulated by estrogen/antiestrogens, whereas YB spheres remained unchanged in size and number. Our results show that alterations in PR isoform balance have an impact on normal and tumorigenic breast progenitor/stem cells and suggest a key role for the B isoform, with implications in response to antiestrogens.

摘要

为了研究 PR 异构体在正常和肿瘤乳腺干细胞自稳态中的作用,我们使用了 PRA 和 PRB 转基因小鼠以及 T47D 人乳腺癌细胞系及其衍生物 T47D YA 和 YB(分别操纵以仅表达 PRA 或 PRB)。流式细胞术和乳腺球体测定显示,在小鼠乳腺中,PRB 的过表达导致腔和基底祖细胞/干细胞增加。卵巢切除术对腔室有负面影响,并仅在 WT 和 PRA 小鼠来源的细胞中诱导乳腺球体形成能力增加。用 ICI 182,780 处理增强了从 WT 和 PRA 小鼠分离的细胞的乳腺球体形成能力,而来自 PRB 的细胞则保持不变。T47D YB 细胞中 CD44/CD24 亚群增加;然而,相对于 T47D 和 YA,肿瘤球体的数量没有变化,尽管它们更大、更不规则且具有更高的克隆形成能力。T47D 和 YA 肿瘤球体受雌激素/抗雌激素调节,而 YB 球体的大小和数量保持不变。我们的结果表明,PR 异构体平衡的改变对正常和致瘤性乳腺祖细胞/干细胞有影响,并表明 B 异构体在对抗雌激素的反应中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/7303dd98d6bd/cells-09-02074-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/f13254d00f39/cells-09-02074-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/6be968d840e1/cells-09-02074-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/ee34018812d3/cells-09-02074-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/6a513e67a5c5/cells-09-02074-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/63bd4dd13275/cells-09-02074-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/0038f7856b5e/cells-09-02074-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/7303dd98d6bd/cells-09-02074-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/f13254d00f39/cells-09-02074-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/6be968d840e1/cells-09-02074-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/ee34018812d3/cells-09-02074-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/6a513e67a5c5/cells-09-02074-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/63bd4dd13275/cells-09-02074-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/0038f7856b5e/cells-09-02074-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/7564437/7303dd98d6bd/cells-09-02074-g007.jpg

相似文献

1
Alterations in Progesterone Receptor Isoform Balance in Normal and Neoplastic Breast Cells Modulates the Stem Cell Population.孕激素受体异构体平衡在正常和肿瘤乳腺细胞中的改变调节干细胞群体。
Cells. 2020 Sep 11;9(9):2074. doi: 10.3390/cells9092074.
2
Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.孕激素依赖型人乳腺癌细胞中血管内皮生长因子的诱导:孕激素受体B的优先调控
Cancer Res. 2004 Mar 15;64(6):2238-44. doi: 10.1158/0008-5472.can-03-3044.
3
Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.乳腺癌中孕激素和抗孕激素反应性是由PRA/PRB比值通过AIB1或SMRT募集至CCND1和MYC启动子驱动的。
Int J Cancer. 2015 Jun 1;136(11):2680-92. doi: 10.1002/ijc.29304. Epub 2014 Nov 12.
4
The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.PR-A 和 PR-B 转基因小鼠的增生表型:雌激素和孕激素受体在乳腺和乳腺癌中作用的启示。
Vitam Horm. 2013;93:185-201. doi: 10.1016/B978-0-12-416673-8.00012-5.
5
Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.孕激素受体异构体 PRA 和 PRB 对新型双诱导乳腺癌细胞系中乳腺癌相关基因的差异调控。
PLoS One. 2012;7(9):e45993. doi: 10.1371/journal.pone.0045993. Epub 2012 Sep 24.
6
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer.孕激素受体异构体依赖性催乳素与脂肪酸合酶在乳腺癌中的相互作用。
Aging (Albany NY). 2020 Dec 10;12(24):24671-24692. doi: 10.18632/aging.202289.
7
Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.差异定量蛋白质组学揭示了与孕激素受体 A 表达的乳腺癌细胞表型变化相关的关键蛋白。
J Steroid Biochem Mol Biol. 2020 Apr;198:105560. doi: 10.1016/j.jsbmb.2019.105560. Epub 2019 Dec 3.
8
The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.纳米化疗颗粒与米非司酮联合使用的有效性取决于乳腺癌临床前模型中的PR异构体比例。
Oncotarget. 2014 May 30;5(10):3246-60. doi: 10.18632/oncotarget.1922.
9
Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.孕激素受体A和B的协同表达缺失是乳腺癌发生过程中的早期事件。
Breast Cancer Res Treat. 2002 Mar;72(2):163-72. doi: 10.1023/a:1014820500738.
10
Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.孕激素受体亚型比例决定抗孕激素/孕激素对乳腺癌生长和转移的影响:NDRG1的作用
Int J Cancer. 2022 May 1;150(9):1481-1496. doi: 10.1002/ijc.33913. Epub 2022 Jan 13.

引用本文的文献

1
Nuclear receptors as novel regulators that modulate cancer radiosensitivity and normal tissue radiotoxicity.核受体作为调节癌症放射敏感性和正常组织放射毒性的新型调节因子。
Mol Cancer. 2025 May 30;24(1):155. doi: 10.1186/s12943-025-02362-2.
2
Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer.孕激素受体信号促进 ER+乳腺癌中癌症相关成纤维细胞介导的肿瘤发生。
Endocrinology. 2024 Jul 26;165(9). doi: 10.1210/endocr/bqae092.
3
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.

本文引用的文献

1
Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates.磷酸化孕激素受体异构体介导相反的乳腺癌干细胞和增殖细胞命运。
Endocrinology. 2019 Feb 1;160(2):430-446. doi: 10.1210/en.2018-00990.
2
Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands.基因表达谱与癌症相关途径与孕激素受体异构体 A(PRA)在转基因小鼠乳腺中的优势相关。
BMC Cancer. 2018 Jun 25;18(1):682. doi: 10.1186/s12885-018-4550-z.
3
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling.
核受体在肿瘤细胞可塑性和耐药性中的动态相互作用:恶性转化中的换挡和癌症治疗中的应用。
Cancer Metastasis Rev. 2024 Mar;43(1):321-362. doi: 10.1007/s10555-024-10171-0. Epub 2024 Mar 22.
4
The Divergent Effects of Ovarian Steroid Hormones in the MCF-7 Model for Luminal A Breast Cancer: Mechanistic Leads for Therapy.卵巢甾体激素在腔 A 型乳腺癌 MCF-7 模型中的多效性作用:治疗的机制线索。
Int J Mol Sci. 2022 Apr 27;23(9):4800. doi: 10.3390/ijms23094800.
5
The Role of Progesterone Receptors in Breast Cancer.孕激素受体在乳腺癌中的作用。
Drug Des Devel Ther. 2022 Jan 26;16:305-314. doi: 10.2147/DDDT.S336643. eCollection 2022.
孕激素受体亚型、激动剂和拮抗剂对雌激素信号传导进行差异性重编程。
Oncotarget. 2017 Sep 28;9(4):4282-4300. doi: 10.18632/oncotarget.21378. eCollection 2018 Jan 12.
4
Membrane and Nuclear Estrogen Receptor Alpha Actions: From Tissue Specificity to Medical Implications.膜和核雌激素受体 α 作用:从组织特异性到医学意义。
Physiol Rev. 2017 Jul 1;97(3):1045-1087. doi: 10.1152/physrev.00024.2016.
5
A Progesterone-CXCR4 Axis Controls Mammary Progenitor Cell Fate in the Adult Gland.孕酮-CXCR4轴调控成年乳腺中乳腺祖细胞的命运。
Stem Cell Reports. 2015 Mar 10;4(3):313-322. doi: 10.1016/j.stemcr.2015.01.011. Epub 2015 Feb 19.
6
Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.孕激素受体亚型比例:一种乳腺癌抗孕激素反应性的预后及预测因子
J Natl Cancer Inst. 2017 Jul 1;109(7). doi: 10.1093/jnci/djw317.
7
Early dissemination seeds metastasis in breast cancer.早期播散种子导致乳腺癌转移。
Nature. 2016 Dec 22;540(7634):552-558. doi: 10.1038/nature20785. Epub 2016 Dec 14.
8
Mechanism of early dissemination and metastasis in Her2 mammary cancer.人表皮生长因子受体2(Her2)阳性乳腺癌早期播散和转移的机制
Nature. 2016 Dec 22;540(7634):588-592. doi: 10.1038/nature20609. Epub 2016 Dec 14.
9
Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.乳腺癌中PR激活形式的肿瘤和细胞分布:一项对大型临床队列的新型免疫组织化学分析
ESMO Open. 2016 Aug 22;1(4):e000072. doi: 10.1136/esmoopen-2016-000072. eCollection 2016.
10
Overview of Mammary Gland Development: A Comparison of Mouse and Human.乳腺发育概述:小鼠与人类的比较
Methods Mol Biol. 2017;1501:1-17. doi: 10.1007/978-1-4939-6475-8_1.